Jan 8, 2022 | Business
Fujitsu today announced that it will raise the standard price of certain products and optional products of the FUJITSU Server PRIMERGY series in Japan as of February 2022.
Amid the impact of the recent global supply shortage of semiconductors and various raw materials on parts and materials procurement, the Fujitsu Group has made every effort to secure parts and materials necessary for production. However, ongoing circumstances, including further increases in procurement and logistics costs, mean that it is no longer possible for Fujitsu to maintain supply prices by absorbing these expenses through efforts to improve production costs and reduce costs across the manufacturing and supply chain. Consequently, Fujitsu has decided to revise the standard prices for some products of the FUJITSU Server PRIMERGY series in Japan, as follows. Fujitsu additionally plans to revise the standard prices in Europe, Asia, Oceania and other countries, and details for each region will be communicated separately at a future date.
Details of Price Revision (in Japan)
1. Target products: Part of x86 server main units and optional products of the FUJITSU Server PRIMERGY series
2. Price revision rate: x86 server main units up about 10%, optional products up about 30%
About Fujitsu
Fujitsu is the leading Japanese information and communication technology (ICT) company offering a full range of technology products, solutions and services. Approximately 126,000 Fujitsu people support customers in more than 100 countries. We use our experience and the power of ICT to shape the future of society with our customers. Fujitsu Limited (TSE:6702) reported consolidated revenues of 3.6 trillion yen (US$34 billion) for the fiscal year ended March 31, 2021. For more information, please see www.fujitsu.com.
Copyright ©2022 JCN Newswire. All rights reserved. A division of Japan Corporate News Network.
Aug 13, 2021 | International
Commencement notice for Mercury Control Ordinance gazetted
**********************************************************
The Government published in the Gazette today (August 13) the Mercury Control Ordinance (Commencement) Notice (the Commencement Notice).
The Legislative Council passed the Mercury Control Bill on June 23 to fully implement the Minamata Convention on Mercury (the Convention). The Mercury Control Ordinance (the Ordinance) regulates matters including the import, export, keeping and use of mercury, mercury mixtures and mercury compounds, as well as the import, export, manufacture and supply of mercury-added products.
The Commencement Notice seeks to appoint December 1, 2021, as the day on which the Ordinance comes into operation.
A spokesman for the Environment Bureau said, “The Ordinance ensures the Hong Kong Special Administrative Region’s full compliance with the international obligations of the Convention, and protects public health and the environment from anthropogenic emissions and releases of mercury and mercury compounds. If the Legislative Council passes the Commencement Notice, the new regulatory system under the Ordinance will take effect on December 1, 2021. Upon the commencement of the Ordinance, the current interim control of elemental mercury trading under the Import and Export (General) Regulations (Cap. 60 sub. leg. A) will be repealed.”
The Commencement Notice will be tabled at the Legislative Council for negative vetting on August 18.
Jul 30, 2021 | Business
The Competition Commission of India (CCI) receives a notice relating to the acquisition of certain shareholding in OFB Tech Private Limited by SVF II Orca (DE) LLC, under Green Channel and is deemed approved.
The CCI received a notice relating to the acquisition of certain shareholding in OFB Tech Private Limited (Target) by SVF II Orca (DE) LLC (Acquirer), under Green Channel and is deemed approved.
SVF II Orca (DE) LLC is a newly incorporated entity set up to make mid to long term financial investments in technology companies. It belongs to the SoftBank Group which is present in India through controlled entities and investments in various sectors, including but not limited to health technology, logistics, education technology, and artificial intelligence.
OFB Tech Private Limited is incorporated in India. It is involved in the wholesale trading of raw materials through a technology enabled platform. OFB Tech has indirect presence in (i) purchase financing business, (ii) wholesale trading of agricultural materials, (iii) wholesale trading of construction materials and related sub-contracting services, and (iv) operation of a technology platform that assists enterprises in discovering tenders.
****
RM/KMN
(Release ID: 1740809)
Visitor Counter : 169
Apr 23, 2021 | Business
Eisai Co., Ltd. announced today that Biogen (Nasdaq: BIIB) has disclosed, in its Q1 2021 Earnings Press Release issued on April 22, its current submission status of the Marketing Authorization Applications (MAA) for aducanumab, an investigational treatment for Alzheimer’s disease, in countries other than the United States, Japan, and in Europe which have been announced previously.
In the first quarter of 2021 Biogen submitted a MAA to Ag?ncia Nacional de Vigil?ncia Sanit?ria (ANVISA) in Brazil for aducanumab an investigational treatment for Alzheimer’s disease. This application is currently in queue for review.
Biogen also submitted MAAs for aducanumab to Health Canada, the Therapeutic Goods Agency in Australia, and Swissmedic in Switzerland, all of which are subject to agency validation of whether the applications are accepted.
Aducanumab is being jointly developed by Biogen and Eisai.
Media Inquiries:
Public Relations Department,
Eisai Co., Ltd.
+81-(0)3-3817-5120
Topic: Press release summary
